Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Painjiabin Tablets Phase IIb Dose-Finding Trial in Focal Epilepsy
CTR20263262Phase 2Active
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of painjiabin in Focal Onset Epilepsy, sponsored by Shanghai Institute of Materia Medica. Started Aug 2026; status: active.
02
Drugs
painjiabin
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on CTR20263262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263262.